Ludwig Schladt
- Co-authors
- Franz OeschAlexius FreybergerHeidrun Ellinger‐ZiegelbauerBettina LawrenzGabriele SchmuckHelmut ThomasP. DostertInge A. Ivens
- Topics
- Eicosanoids and Hypertension Pharmacology (11 papers)Pharmacogenetics and Drug Metabolism (9 papers)Biochemical Acid Research Studies (7 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Ludwig Schladt
20 papers receiving 604 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 295
- Pharmacology 168
- Biochemistry 155
- Cancer Research 85
- Physiology 60
Countries citing papers authored by Ludwig Schladt
This map shows the geographic impact of Ludwig Schladt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwig Schladt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwig Schladt more than expected).
Fields of papers citing papers by Ludwig Schladt
This network shows the impact of papers produced by Ludwig Schladt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwig Schladt. The network helps show where Ludwig Schladt may publish in the future.
Co-authorship network of co-authors of Ludwig Schladt
This figure shows the co-authorship network connecting the top 25 collaborators of Ludwig Schladt. A scholar is included among the top collaborators of Ludwig Schladt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludwig Schladt. Ludwig Schladt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 228 | |
| 3 | 16 | |
| 4 | 11 | |
| 5 | 10 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 10 | |
| 9 | 72 | |
| 10 | 13 | |
| 11 | 24 | |
| 12 | 12 | |
| 13 | 18 | |
| 14 | 14 | |
| 15 | 11 | |
| 16 | 22 | |
| 17 | 3 | |
| 18 | 41 | |
| 19 | 17 | |
| 20 | 59 |
About Ludwig Schladt
Ludwig Schladt is a scholar working on Biochemistry, Pharmacology and Clinical Biochemistry, having authored 20 papers that have together received 624 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (11 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Biochemical Acid Research Studies (7 papers). The work is most often cited by research in Biochemistry (155 citations), Pharmacology (168 citations) and Clinical Biochemistry (49 citations). Ludwig Schladt has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Franz Oesch, Alexius Freyberger, Heidrun Ellinger‐Ziegelbauer, Bettina Lawrenz, Gabriele Schmuck, Helmut Thomas, P. Dostert, Inge A. Ivens, E. Bomhard and Pablo Steinberg. Their work appears in journals such as Scientific Reports, Biochemical Journal and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.